Benitec Biopharma Inc stock is traded at $9.47, with a volume of 120,638. It is up +2.05% in the last 24 hours and up +4.41% over the past month. Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Previous Close:
$9.28
Open:
$9.42
24h Volume:
120,638
Relative Volume:
0.59
Market Cap:
$330.40M
Revenue:
$7,000
Net Income/Loss:
-$41.54M
P/E Ratio:
-
EPS:
-$0.929
Net Cash Flow:
-$20.57M
1W Performance:
+9.61%
1M Performance:
+4.41%
6M Performance:
-20.02%
1Y Performance:
-29.54%
1-Day Range:
$9.20$9.59
1-Week Range:
$8.56$10.23
52-Week Range:
$7.89$14.39
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma IncSector
HealthcareIndustry
BiotechnologyPhone
(510) 780-0819Address
3940 TRUST WAY, HAYWARD, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS